Skip to content

Care&D: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Care&D

BE 0676.669.426
NACE 72.101, Research and development on biotechnology
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€17,929
2024 · -€7,474+€25,403
Equity
€64,428
2024 · €46,499+€17,929
Cash
€23,470
2024 · €24,191-€721
Balance sheet total
€112,187
2024 · €90,576+€21,611

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€13,038

    up €13,038 (+20.3%), from €64,100 to €77,139

    of which Trade receivables: +€13,148

  • Deferred charges and accrued income +€9,294

    up €9,294 (+407%), from €2,285 to €11,579

Equity and liabilities
  • Profit (loss) carried forward +€17,929

    up €17,929 (+68.7%), from €26,094 to €44,023

  • Trade debts +€2,617

    up €2,617 (+26.8%), from €9,750 to €12,367

Income statement
  • Gross operating margin +€57,337

    up €57,337 (+37.9%), from €151,281 to €208,618

  • Staff costs +€32,152

    up €32,152 (+21.6%), from €148,635 to €180,787

  • Other operating charges -€9,990

    down €9,990 (-100%), from €9,990 to €0

  • Write-downs +€9,525

    new in 2025: €9,525

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€7,474
Gross operating margin +€57,337
Staff costs -€32,152
Write-downs -€9,525
Other operating charges +€9,990
Other operating items -€23
Financial income -€9
Financial charges -€215
Result 2025 €17,929
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€721
Investment €0
Financing €0
Cash 2024 €24,191
Net result for the year +€17,929
Receivables within one year -€13,038
Deferred charges and accrued income -€9,294
Trade debts +€2,617
Tax, wage and social debts +€1,064
Cash 2025 €23,470
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €90,576 €112,187 +€21,611 +23.9%
Current assets 29/58 €90,576 €112,187 +€21,611 +23.9%
Amounts receivable within one year 40/41 €64,100 €77,139 +€13,038 +20.3%
Trade receivables 40 €63,991 €77,139 +€13,148 +20.5%
Other amounts receivable 41 €110 €0 -€110 -100%
Cash at bank and in hand 54/58 €24,191 €23,470 -€721 -3.0%
Deferred charges and accrued income 490/1 €2,285 €11,579 +€9,294 +407%
Total equity and liabilities 10/49 €90,576 €112,187 +€21,611 +23.9%
Equity 10/15 €46,499 €64,428 +€17,929 +38.6%
Contributions 10/11 €18,550 €18,550 = 0.0%
Reserves 13 €1,855 €1,855 = 0.0%
Distributable reserves 133 €1,855 €1,855 = 0.0%
Profit (loss) carried forward 14 €26,094 €44,023 +€17,929 +68.7%
Amounts payable 17/49 €44,078 €47,759 +€3,682 +8.4%
Amounts payable within one year 42/48 €44,078 €47,759 +€3,682 +8.4%
Trade debts 44 €9,750 €12,367 +€2,617 +26.8%
Suppliers 440/4 €9,750 €12,367 +€2,617 +26.8%
Taxes, remuneration and social security 45 €34,328 €35,392 +€1,064 +3.1%
Taxes 450/3 €9,827 €10,696 +€868 +8.8%
Remuneration and social security 454/9 €24,501 €24,697 +€196 +0.8%
Remuneration, social security and pensions 62 €148,635 €180,787 +€32,152 +21.6%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €9,525 +€9,525
Other operating charges 640/8 €9,990 €0 -€9,990 -100%
Non-recurring operating charges 66A - €23 +€23
Gross operating margin 9900 €151,281 €208,618 +€57,337 +37.9%
Operating profit (loss) 9901 -€7,345 €18,282 +€25,627
Financial income 75/76B €9 €0 -€9 -100%
Recurring financial income 75 €9 €0 -€9 -100%
Financial charges 65/66B €138 €353 +€215 +155%
Recurring financial charges 65 €138 €353 +€215 +155%
Profit (loss) for the period before taxes 9903 -€7,474 €17,929 +€25,403
Profit (loss) for the period 9904 -€7,474 €17,929 +€25,403
Profit (loss) for the period to be appropriated 9905 -€7,474 €17,929 +€25,403

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.